[Coronary stenting. Does AT-1 blocker protect from restenosis?].
D015906:Angioplasty, Balloon, Coronary; D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D018849:Controlled Clinical Trials as Topic; D023903:Coronary Restenosis / Q000517:prevention & control*; D006801:Humans; D010919:Placebos; D015607:Stents; D013777:Tetrazoles / Q000627:therapeutic use*; D014633:Valine / Q000031:analogs & derivatives / Q000627:therapeutic use*; D000068756:Valsartan
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents; D010919:Placebos; D013777:Tetrazoles; D000068756:Valsartan; D014633:Valine